Literature DB >> 12692514

Inherited aplastic anaemia.

Inderjeet Dokal1.   

Abstract

A number of inherited (constitutional/genetic) disorders are characterized by bone marrow (BM) failure/aplastic anaemia (AA) usually in association with one or more somatic abnormality. Occasionally, these patients may present with AA alone and be labelled to have idiopathic AA. In recent years, there have been significant advances in the genetics of Fanconi anaemia (FA), dyskeratosis congenita (DC) and other BM failure syndromes. This is facilitating accurate diagnosis and beginning to unravel their pathophysiology. Furthermore, these advances are also providing important insights into normal haemopoiesis and how this might become defective in some patients presenting with the more common idiopathic AA. Indeed, a link between DC and idiopathic AA and in turn to defective telomerase has now been established. This advance also suggests that treatments directed at correction of telomerase activity might benefit AA patients who do not respond to conventional therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692514     DOI: 10.1038/sj.thj.6200215

Source DB:  PubMed          Journal:  Hematol J        ISSN: 1466-4860


  4 in total

Review 1.  Topics in pediatric leukemia--Fanconi's anemia: new insights.

Authors:  Noah Federman; Kathleen M Sakamoto
Journal:  MedGenMed       Date:  2005-04-06

Review 2.  The short and long telomere syndromes: paired paradigms for molecular medicine.

Authors:  Susan E Stanley; Mary Armanios
Journal:  Curr Opin Genet Dev       Date:  2015-07-29       Impact factor: 5.578

3.  Oxymetholone therapy of fanconi anemia suppresses osteopontin transcription and induces hematopoietic stem cell cycling.

Authors:  Qing-Shuo Zhang; Eric Benedetti; Matthew Deater; Kathryn Schubert; Angela Major; Carl Pelz; Soren Impey; Laura Marquez-Loza; R Keaney Rathbun; Shigeaki Kato; Grover C Bagby; Markus Grompe
Journal:  Stem Cell Reports       Date:  2014-11-26       Impact factor: 7.765

4.  In Vivo RNAi Screen Unveils PPARγ as a Regulator of Hematopoietic Stem Cell Homeostasis.

Authors:  Mathieu Sertorio; Wei Du; Surya Amarachintha; Andrew Wilson; Qishen Pang
Journal:  Stem Cell Reports       Date:  2017-04-13       Impact factor: 7.765

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.